Abdominal obesity prevalence in Latin America: a systematic review and meta-analysis comparing ATP III and IDF criteria

拉丁美洲腹型肥胖患病率:一项比较ATP III和IDF标准的系统评价和荟萃分析

阅读:1

Abstract

BACKGROUND: Abdominal obesity (AO) represents a significant cardiovascular risk factor with distinctive characteristics in Latin American populations. Its prevalence has increased substantially in recent decades, although estimates vary according to the diagnostic criteria. OBJECTIVE: To determine the prevalence of AO in Latin American populations through a systematic review with meta-analysis, comparing ATP III and IDF criteria. METHODS: A systematic search was conducted across SCOPUS, Web of Science, PubMed, and EMBASE databases. Observational studies evaluating AO prevalence in Latin American populations using either ATP III (≥102/88 cm) or IDF (≥90/80 cm) criteria were included. Meta-regressions were performed to assess the influence of publication year and sample size. RESULTS: Sixty-one studies were included (n=281,694 participants). The pooled prevalence according to ATP III criteria was 40% (95% CI: 34-46%) and 62% (95% CI: 56-68%) according to IDF criteria. Sex-stratified analysis revealed significantly higher prevalences in women (ATP III: 50% vs 27%; IDF: 74.3% vs 46.8%). Temporal meta-regression demonstrated an upward trend, particularly in studies utilizing IDF criteria, while sample size showed no significant influence on prevalence estimates. Substantial geographic variations were observed, with Mexico and Venezuela exhibiting the highest prevalences. Heterogeneity was considerably high (I²>99%) across all analyses. CONCLUSIONS: AO prevalence in Latin America is high and demonstrates significant sexual dimorphism. These findings challenge the validity of current cut-off points and suggest the need to develop Latin American-specific criteria based on clinically relevant outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。